Sign In
Buy DNA
$7.89
-0.110 (-1.38%)
At Close: Jun 12, 2026
Twist Bioscience and Ginkgo Bioworks Revise Collaboration
08:00am, Thursday, 08'th May 2025
SOUTH SAN FRANCISCO, Calif. & BOSTON--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care secto
Ginkgo Bioworks Holdings, Inc. (DNA) Q1 2025 Earnings Call Transcript
09:19pm, Tuesday, 06'th May 2025
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA ) Q1 2025 Results Conference Call May 6, 2025 5:00 PM ET Company Participants Daniel Marshall - Sr. Manager, Communications and Ownership Jason Kelly - Co-Foun
Ginkgo Bioworks Holdings, Inc. (DNA) Reports Q1 Loss, Tops Revenue Estimates
07:30pm, Tuesday, 06'th May 2025
Ginkgo Bioworks Holdings, Inc. (DNA) came out with a quarterly loss of $1.58 per share versus the Zacks Consensus Estimate of a loss of $1.23. This compares to loss of $3.20 per share a year ago.
Ginkgo Bioworks Reports First Quarter 2025 Financial Results
05:00pm, Tuesday, 06'th May 2025
Ginkgo provides an update on its restructuring, including progress towards its expanded $250 million cost savings target Ginkgo and partners awarded $29 million contract by ARPA-H to develop distribut
Twist Bioscience Spins Out DNA Data Storage as Independent Company
07:10am, Monday, 05'th May 2025
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Slides as Market Rises: Facts to Know Before You Trade
07:20pm, Wednesday, 30'th Apr 2025
The latest trading day saw Ginkgo Bioworks Holdings, Inc. (DNA) settling at $7.37, representing a -0.14% change from its previous close.
Replacing artificial dyes with natural colors has become a national priority, moved by consumer demand, regulation, and governmental pressure. Achieving this milestone—by increasing coloring efficie
Ginkgo Bioworks Announces Date of First Quarter 2025 Results Presentation
04:00pm, Tuesday, 29'th Apr 2025
Presentation and Q&A session scheduled for post-market on Tuesday, May 6, 2025 BOSTON , April 29, 2025 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leadi
Ginkgo Bioworks Holdings, Inc. (DNA) Rises Yet Lags Behind Market: Some Facts Worth Knowing
07:21pm, Wednesday, 23'rd Apr 2025
In the latest trading session, Ginkgo Bioworks Holdings, Inc. (DNA) closed at $7.60, marking a +0.8% move from the previous day.
Ginko Automation Partners with Aura Genetics to Accelerate Direct-to-Consumer Testing and Innovation
09:00am, Tuesday, 22'nd Apr 2025
BOSTON , April 22, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that Ginkgo Automation will design an
- Pivot to U.S.-based Supply Chain for Critical Input Materials Completed - STONY BROOK, NY / ACCESS Newswire / April 21, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA or the "Company")
Indian Patent Office Grants Acurx Patent for DNA Polymerase IIIC Inhibitors
07:30am, Thursday, 17'th Apr 2025
STATEN ISLAND, N.Y. , April 17, 2025 /PRNewswire/ -- Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molec
Ginkgo Bioworks Teams Up with Partners on ARPA-H Project to Stabilize Pharmaceutical Supply Chains - Using Amber Waves of Grain
09:00am, Thursday, 10'th Apr 2025
Ginkgo Bioworks and partners awarded $29 million contract by ARPA-H to develop distributed manufacturing of essential medicines using wheat germ cell-free expression systems BOSTON , April 10, 2025 /P
23andMe probe launched to prevent customer DNA data from being sold to China or other bad actors
10:16am, Wednesday, 09'th Apr 2025
Sen. Bill Cassidy is probing 23andMe, which recently filed for bankruptcy protection, to ensure the company does not sell customer data to China or other foreign adversaries.
Focus Graphite Advanced Materials Commences Work Program with AETC for C4V Digital DNA(TM) Testing and Strategic Specialty Applications
05:00am, Wednesday, 09'th Apr 2025
Exclusion of Canadian natural graphite from President Trump's "Liberation Day" U.S. Tariffs underscores urgency to fast-track testing and qualification with industry partners. OTTAWA, ON / ACCESS News
